micro needles in drug deliveryf
TRANSCRIPT
Microneedles in Drug Delivery system 2010-11
1. Introduction
1.1 The concept of minimally invasive drug delivery
A discussion of minimally invasive drug delivery must begin with a consideration of
what invasive delivery means. Administration of drugs via needles and syringes has been
with us for more than a hundred years. For example, the first all-glass syringe patent was
licensed to Becton Dickinson & Co. in 1898. Metal cannula needles on piston syringes
have become the most prevalent ethical device-based drug delivery modality in existence,
with multiple billions being used each year in many health care applications.
Conventional needles, whether on syringes or catheters, represent the preeminent
invasive delivery mode in existence. They are, however, also the most efficient and cost
effective device-based system for administering agents into the systemic circulation and
are presently the general method for delivering polypeptide agents, which are otherwise
proteolyzed by the oral route. The reason, as discovered more than a century ago, is that a
thin, sharp sterile metal pipe is an ideal way to breach the stratum corneum and deliver
agents past the skin barrier into the micro-vascularization of the dermis or lower tissues
and thence into the systemic circulation. Despite this, conventional needle-based delivery
suffers many well-recognized drawbacks, not the least of which is the negative
psychosocial connotation of drug administration via needles. Other problems include the
pain of administration; safety concerns over the possibility of transmission of blood-
borne pathogens; the lack of compliance, the inability or dislike of patients to self-
administer via needles; and the lack of ease of use, especially for younger or elderly
patients. To address these needs, a number of new technologies have arisen or are in
development, whose inventors intend to provide trans-epidermal drug delivery by
circumventing the conventional needle and syringe.1
During recent years, transdermal drug delivery systems have shown a tremendous
potential for their ever-increasing role in health care. This has been mainly attributed to
the favourable properties of lack of first pass metabolism effects of liver, better patient
compliance, steady release profile and lowered pill burden in transdermal system.
However, the transdermal technology have limitations due to the inability of a large
majority of drugs to cross the skin at the desired therapeutic rates because of the presence
of a relatively impermeable thick outer stratum corneum layer. This barrier posed by
Chetan N. Chauhan 1 SSPC, Mehsana
Microneedles in Drug Delivery system 2010-11
human skin limits transdermal delivery only to lipophilic, low molecular weight potent
drugs.2 Researchers are trying to overcome this hurdle of poor permeability by the
following means:
1) Chemical Means: Chemical means include the prodrug approach and/or use of
chemical penetration enhancers that can improve the lipophilicity, and the consequent
bioavailability.
Chemical approach increases the lipophilicity and therefore increase the permeability of
drugs across skin, whereas the physical approaches disrupt the upper layers of skin
(stratum corneum) and reduce the resistance to the passage of drugs by creating minute
holes in the skin that are large enough for the passage of smaller drug molecules but
probably small enough not to damage the skin.
2) Physical Means: Physical means of transdermal drug delivery comprises of
iontophoresis, electroporation, and sonophoresis.
On the other hand hypodermic needles are effective at bolus delivery of drugs, but cause
pain during insertion and are not ideally suited for delivery over extended periods.
Transdermal patches address these shortcomings.
Chetan N. Chauhan 2 SSPC, Mehsana
Microneedles in Drug Delivery system 2010-11
1.2 Mechanism of skin penetration
The thickness of the stratum corneum is approximately 10 to 20 microns. Therefore the
minimum distance breached by minimally invasive transdermal systems must be about 20
microns. During tissue damage, adenosine triphosphate (ATP) is released from damaged
cells. ATP is a ubiquitous cellular energy storage compound, which when released
extracellularly potentiates input nociceptors (pain receptors) via direct stimulation of
neurons. The effect appears to provide a local signal for tissue destruction, which in turn
stimulates remedial physiological responses such as inflammation, etc. Pain may also
result from tissue distension caused by drug injection, skin damage (and ATP release), or
direct damage to nerves. Researchers are approaching the challenge of pain reduction by
several techniques that are linked by one unifying strategy: limiting the extent of
mechanical insult to skin to the first 50 microns of tissue.
The mechanical stress–strain relationships of skin complicate the practical manipulation
of the stratum corneum, epidermis, and upper dermal layers. The mechanics of skin, and
other soft tissue such as arteries, muscle, and ureter, do not display single-value
relationships between stress and strain and are therefore classified as inelastic materials.
When tissues in this group are held at constant strain, they display stress relaxation, and
when held at constant stress they creep.2, 3
Historically this relationship has required uniaxial application of mechanical force to
breach skin (as in needle penetration), and has made sensation-free clinical manipulation
(containment, preparation, and breach) of skin tissue difficult. In general the new skin
breach technologies described in this communication require either direct uniaxial
application of mechanical energy or thermally/mechanically induced changes in the
physical properties or structure of skin. They differ from classical approaches in that they
attempt to target the epidermis and upper dermal layers devoid of nosiceptors while
gaining access to the circulatory and immune systems via the dermal capillary bed and
epidermis, respectively. If successful, these approaches may greatly reduce or eliminate
the mechanical stimulation of pain responses during delivery.
Chetan N. Chauhan 3 SSPC, Mehsana
Microneedles in Drug Delivery system 2010-11
1.3 Microneedles as a system for minimally invasive transdermal delivery
The development of microneedles for transdermal drug delivery came about as an
approach to enhance the poor permeability of the skin by creating microscale conduits for
transporting across the stratum corneum. Microneedle technology has been developed as
an advanced technique for penetration of large molecular weight and/or hydrophilic
compounds. Micron scale needles assembled on a transdermal patch have been proposed
as a hybrid between hypodermic needles and transdermal patches to overcome the
individual limitations of both the injections as well as patches. Microneedles are so called
because they are of micrometre (millionths of a metre) scale.
Microneedle technique has been successfully used to deliver a variety of compounds
including macromolecules and hydrophilic drugs into the skin. As microneedle system
bypasses the stratum corneum barrier of the skin, permeability enhancement of two to
four orders of magnitude has been observed for small molecules like calcein and also for
the relatively larger compounds like proteins and nanoparticles. The technology that are
long and robust enough to penetrate the layer of the stratum corneum but short enough to
avoid stimulating the nerves has the potential to make the transdermal delivery of drugs
more effective. Therefore, the main aim of the microneedle technology is to combine the
efficacy of the hypodermic needle with the convenience of a transdermal patch.
Figure 1: Layers of the Human Skin
Chetan N. Chauhan 4 SSPC, Mehsana
Microneedles in Drug Delivery system 2010-11
In modern medical applications, there is a need for very small hypodermic needles that
are economical to fabricate. Currently, the smallest needles commercially available, 30
gauge needles, have a 305 mm outer diameter with a wall thickness of 76 mm.
Traditional machining methods make it unfeasible to create needles with a diameter
less than 300 mm. Microneedles on the other hand can be any size and geometry since
they are defined lithographically. Microneedles are designed to be high performance
minimally invasive conduits, through which drug solutions may pass into the body. In
order to be minimally invasive, the needles are designed to be as small as possible.
Needles are also designed to be extremely sharp, with submicron tip radii. This allows
the needles to be effectively inserted into the skin. The stress on the skin is inversely
proportional to the area over which the force is applied.3, 29, 31
Therefore as tip radii decreases the stress imposed at a constant force increases and
allows lower forces to be used for needle insertion. In addition, the small size of the
needles cause less compression of the tissue as needles are inserted which leads to less
compression of pain receptors and a decrease in insertion discomfort. The small size of
the microneedles also decreases the chance that the needle will be inserted close to a
pain receptor. The decrease in tissue damage also decreases the likelihood of infection
occurring at the site of insertion. Internal features of the microneedle, such as in-line
microfilters, which are defined as part of the needle during a lithography step, may also
be used to effectively filter any foreign matter including bacteria from the fluid being
injected. This decreases the chance that a contaminated solution may be inadvertently
injected.
One of the largest barriers to the commercialization of technology is the cost and
effectiveness of producing the technology. Since microneedles are produced in a highly
parallel batch process there is great potential that the individual cost per needle is
lowered. Molded needles which do not sacrifice the mold wafers lead to an increased
cost savings, since the mold may be used over and over. This leads to a high quality
reproducible device that opens up a new option for drug delivery applications that has
few cost and fabrication barriers to being employed in the marketplace.5
Chetan N. Chauhan 5 SSPC, Mehsana
Microneedles in Drug Delivery system 2010-11
2. Advantages & Disadvantages
2.1 Advantages
The major advantage of microneedles over traditional needles is, when it is inserted into
the skin it does not pass the stratum corneum, which is the outer 10-15 μm of the skin.
Conventional needles which do pass this layer of skin may effectively transmit the drug
but may lead to infection and pain. As for microneedles they can be fabricated to be long
enough to penetrate the stratum corneum, but short enough not to puncture nerve endings.
Thus reduces the chances of pain, infection, or injury. 5
In terms of processing there are also many advantages. By fabricating these needles on a
silicon substrate because of their small size, thousands of needles can be fabricated on a
single wafer. This leads to high accuracy, good reproducibility, and a moderate
fabrication cost
Microneedles have a significant advantage over other approaches to transdermal drug
delivery such as electroporation, ultrasonic delivery, or chemical modifiers/enhancers all
of which rely on decreasing the permeation barrier of the stratum corneum, the outermost
layer of the skin. Microneedles mechanically penetrate the skin barrier and allow the
injection of any volume of fluid over time. Microneedles have the ability to be precisely
inserted to inject therapeutics any particular distance below the stratum corneum. This
allows precise localization of a high concentration drug solution in order to obtain
effective absorption into the bloodstream or to stimulate particular clusters of cells in or
near the skin. Therefore, the drug delivery does not depend on transient delivery of
therapeutics across the skin. The delivery is independent of the drug composition and
concentration and merely relies on the subsequent drug absorption into the bloodstream,
which occurs at a much faster rate than permeation of a solution across the skin. This also
allows complex drug delivery profiles. Since drug is actively injected into a patient the
dosage may be varied with time. In addition, by employing multiple needles or effective
fluid control with mixing of solutions multiple drugs may be injected simultaneously
specific to a patient’s personal needs. Needles may also be used to transdermally sample
body fluids for analysis. 4
The extreme miniaturization of fluidic devices enables portable devices for
personalized medicine allowing continuous metabolite monitoring with drug delivery in
Chetan N. Chauhan 6 SSPC, Mehsana
Microneedles in Drug Delivery system 2010-11
response to metabolite levels. This has tremendous advantages over existing
technologies. It allows patients more freedom in their treatment since they are no longer
dependent on a facility to provide an outpatient service which often results in a bolus
injection or a period of intravenous drug delivery while a patient is at the facility with
little or no therapy between treatments. It also allows a lower drug dosage to be injected
over a longer period of time to maintain a constant blood concentration. A bolus
injection on the other hand leads to a rapid increase in blood concentration, often to
toxic levels, followed by a decay period as the drug is metabolized. This time varying
high concentration injection is often responsible for many side effects associated with a
large number of therapeutics. By maintaining a constant blood concentration below
toxic levels, side effects associated with a high concentration bolus injection may be
reduced. Further, the ability of microneedles to deliver therapeutics at a slow,
controlled rate will make unnecessary the injection of a large bolus in the first place.
This allows the delivery of therapeutics to a depth just below the stratum corneum and
yet still above the nerve bed in the skin. A bolus must be injected deeply into the tissue so
it does not leak out the hole punched in the skin to deliver it. Microneedles make this
form of therapeutic delivery unnecessary.
Other advantages include: 8
Precise volumes of fluid moved rapidly and efficiently
Reduce the amount of drug used
Localize the delivery of potent compounds
Deliver otherwise insoluble or unstable therapeutic compounds
Reduce the chances of missing or erring a dose
Multiple injections can be avoided
Ability to administer the drug at the specific target site
Rapid onset of action
Possible self administration
Efficacy and safety comparable to approved injectable products
Improved patient compliance
Good stability
Cost effective
Chetan N. Chauhan 7 SSPC, Mehsana
Microneedles in Drug Delivery system 2010-11
2.2 Current limitations of microneedles
Biological Response
Future work needs to be performed to determine the biological response to microneedles.
The first response to tissue distress from needle insertion is an inflammatory response at
the insertion site. Also, constriction of capillaries may occur which may affect drug
absorption. During this time tissue edema may also occur, which may affect fluid
delivery from the needles, with the migration of leukocytes to the injury site. Protein
adsorption to the surface of the silicon will promote adhesion of leukocytes to the
needles. However, surface modifications of silicon surfaces to reduce protein adsorption
is an active area of research. Some surface modifiers include: silicon carbide,
polyethylene glycol (PEG), or plasma enhanced chemical vapor deposition (PECVD) of a
Teflon-like fluoropolymer. Any of these coatings could be incorporated into needle
fabrication to improve biocompatibility.
Since microneedles are designed for short term intradermal drug delivery, fibrous
encapsulation is not expected because the needle is not inserted long enough for
encapsulation to occur. However, there is the chance that the body may try to extrude the
needle by pushing it out over time. Therefore, mechanical reinforcement may be required
to keep the needle in place.2
Breakage Versus Piercing Ability
Due to the small size of microneedles, strength and robustness are the major factors in
determining the range of their applications. Needles must be able to tolerate forces
associated with insertion, intact removal and normal human movements if they are to be
integrated into portable biomedical devices. Namely, materials such as silicon are strong
and can easily pierce the skin but they are also brittle materials which fracture easily.
Metal and polymer needles on the other hand are not stiff so they can absorb larger
stresses by plastically deforming. However, this ability also makes piercing the skin more
difficult. Metal deposition also uses thin film processing techniques, and therefore the
metals are mechanically weaker than bulk hardened metals such as stainless steel. A
hybrid microneedle such as the parylene coated silicon needle appears to be most
promising because it balances the advantages of each material. A silicon tip could be held
Chetan N. Chauhan 8 SSPC, Mehsana
Microneedles in Drug Delivery system 2010-11
rigid during insertion and then released allowing the polymer tube to absorb the stress
associated with movement. Since the silicon tip is so much smaller than a whole needle it
will experience smaller stresses and will be less likely to fracture. In addition, even if the
tip does fracture it will be held together by the polymer coating. Another approach is to
develop new polymer processing techniques which can be used to generate needles. If a
semi-crystalline polymer is used, then it may be strong enough to allow needle insertion,
but also have enough of the polymer in an amorphous phase to absorb mechanical stress.
Another way to take advantage of material limitations is to precisely control the stresses
and forces the needle experiences. This could be accomplished by having a
microfabricated insertion actuator to control the insertion force. This could consist of a
microfabricated linear stepper motor or piezoelectric actuator. Both would allow precise
positioning and direct insertion of the needles axially without any bending moment to
deform or fracture the needles. Piezoelectric actuators could also produce ultrasonic
vibrations to decrease the amount of force required for insertion.4
Chetan N. Chauhan 9 SSPC, Mehsana
Microneedles in Drug Delivery system 2010-11
3. Applications
3.1 Diabetes
Microfluidic devices and sampling through a microneedle allows a feedback loop
between a sensor which monitors the glucose levels in the body and a delivery module
which can deliver insulin in a time varying fashion as needed. This more closely
mimics the body’s natural regulation of sugar leading to fewer complications associated
with the treatment.2
3.2 Chemotherapy
When a patient undergoes chemotherapy they often receive a fixed drug dosage in a
session. By delivering the chemotherapeutic agents continuously through a
microneedle, the patient may receive therapy over a longer period of time. It could also
lead to a lower dosage of the toxic drugs, which must be injected at any one time.
Lowering chemotherapy dosages may lead to an overall lessening of the severity of side
effects. By incorporating a longer treatment period with fewer side effects, it could
shorten the overall number of treatments and recovery time to combat the disease.
There are also many cell based therapies which could be delivered continuously
through a microneedle. Antitumor effector cells which attack melanomas have been
extensively studied. These cells have been shown to reduce the size of both solid and
hematologic human tumors. However, if cells are injected intravenously they are not
always localized to tumors and the liver and spleen destroy a large majority of the cells.
If the injection is directly into or around tumors (intralesionally), they will be localized
to attack the tumor. The microneedles do very little tissue damage, so a patient can
receive continuous therapy. Also, the needles have less chance of damaging tumors and
causing the tumor to metastasize than larger needles. 2, 9
3.3 Vaccinations, Pain relievers and Antibiotics
Currently there are many medications, such as the Hepatitus B vaccine, which require
several shots over a period of time. Quite often, people will receive the first or second
shot but fail to return for subsequent shots. Patients also take antibiotics until their
symptoms subside but then do not finish their pills. This is leading to a dramatic
increase in antibiotic resistant bacteria strains. Analgesics such as Sufanta (Sufentanil
Citrate), Sublimaze (Fentanyl Citrate), and Dilaudid (Hydromorphone) have doses of
Chetan N. Chauhan 10 SSPC, Mehsana
Microneedles in Drug Delivery system 2010-11
less than 3 ml per hour. By delivering these pain relievers continuously, a patient can
obtain the benefits of the analgesic without being hindered by a intravenous drip.
Delivery of all of these medications in a continuous fashion greatly simplifies the
therapy. A patch device could be applied once a day or every few days and supply the
patient with enough medication for a given time period. In addition, the drug could be
kept in a lyophilized powder. The powder would be reconstituted with water, dosed,
and delivered as needed by the patient. 2
3.4 Catheterized Instrumentation
Microneedles may be placed on the end of a catheter for intervascular delivery. The
needle could be used to breach blood vessel walls in order to inject precise dosages of
drugs to the surrounding tissue. They may be used to inject clot-dissolving drugs
directly into a coronary arteriosclerosis such as alteplase (a genetically engineered form
of one of the body's own plasminogen activator proteins) or Streptokinase (a
plasminogen activator produced by streptococcus bacteria)20
3.5 Blood glucose measurements
Recent advancement involves the instrument in which a patient will load the cartridge
into the electric monitor and simply press the monitor against the skin. This action will
cause the microneedle to penetrate the skin and drain a very small volume of blood(less
than 100 nanolitres) into the disposable. Chemical agents in the disposable react with the
glucose in the blood to give a colour. The blood glucose concentration will be measured
either electrochemically or optically and the resultant value displayed on the monitor.
The use of hollow microneedles allows the delivery of medicine, insulin, proteins or
nanoparticles that would encapsulate a drug or demonstrate the ability to deliver a virus
for vaccination. An assay of needles can be designed to puncture the skin and deliver the
drug much like a nicotine patch for individuals who are trying to quit smoking.38
3.6 Skin therapy
Microneedle skin therapy is s till in testing development but it seems to show much
promise. Microneedle therapy is a way to rejuvenate the skin without destroying the
epidermis. It is similar to laser treatment but with less damage. Microneedles penetrate
the epidermis and break away old collagen strands. The collagen strands that are
destroyed create more collagen under the epidermis. This leads to youthful looking skin.
Chetan N. Chauhan 11 SSPC, Mehsana
Microneedles in Drug Delivery system 2010-11
The only disadvantage of this method is that it causes blood oozing, which laser
treatments do not. It does however have advantages such as: increased collagen, non sun-
sensitivity upon treatment, no breaking of the epidermis, lower cost, and ease of
application.20
3.7 Eye Treatment
Microneedles can be used to deliver drugs to the eye through a minimally invasive
procedure. The needles used to penetrate the eye only go as deep as half a millimetre into
the eye tissue. This means that the needles do not penetrate far enough to cause as much
damage as traditional needles. As a result, they can be applied to the eye using only local
anaesthetic. This technique has the potential to revolutionise the way of treating common
eye conditions such as glaucoma, macular degeneration and diabetic retinopathy.
Other applications of microneedles include: 26, 24, 39
Cell manipulation.
Interconnection between microscopic and macroscopic fluidic systems.
Chetan N. Chauhan 12 SSPC, Mehsana
Microneedles in Drug Delivery system 2010-11
4. Classification – Types & Approaches
Microneedles can be classified into various types as shown below:
4.1 Types of Microneedles:
Figure 2: Classification of Microneedles
4.1.1 Solid Microneedles
Solid microneedles are designed to create micron-size pores in the tissue, which act as
direct pathways allowing drug molecules or particles to transport into the tissue. These
microneedles tend to have sharp tips and have good mechanical strength. They can be
mass-produced at low cost. These are of various types and as shown above, can be
fabricated from various materials: 9, 15, 22
4.1.1.1 Silicon Microprobes 18, 27
In the early phase of microneedle development, pyramidal silicon microprobes were
found. Using a spin casting method, a photoresist is placed onto a silicon-dioxide coated
wafer; the wafer is then brought in contact with a photomask and is exposed to UV light.
The transferred pattern is then etched into the silicon dioxide masking layer. The
photoresist is then removed and the wafer is anisotropically wet-etched in potassium
hydroxide solution to create arrays of pyramidal probes. With the goals of delivering
Chetan N. Chauhan 13 SSPC, Mehsana
Microneedles in Drug Delivery system 2010-11
genetic materials to cells, these microprobles are ten to hundreds of microns in height and
have very sharp tips. 28, 41
4.1.1.2 Silicon microneedles
Figure 3: Silicon Microneedles
The simplest forms of the microneedles are solid spikes. Besides being solid, their
unifying characteristics include being very sharp and usually had fairly simple fabrication
schemes. Using a deep-reactive ion etching method, silicon microneedles were
fabricated. The fabrication steps include depositing a chromium masking layer onto a
silicon wafer, patterning it using photolithography into dots with the size of the desired
needle base. The wafer is etched with an oxygen/fluorine plasma mixture to create the
high aspect ratio silicon microneedles. These needles were used to create micron-scale
holes in the skin through which molecules can be more easily transported. Silicon is
preferred material for fabrication because it has the following characteristics.16, 43
Silicon is abundant, inexpensive, and of high purity and perfection
Silicon processing is highly amenable to miniaturization
Photolithographic patterning allows for rapid evaluation of design ideas
Batch-fabrication results in high volume manufacturing at low unit cost
Silicon is also a biocompatible material (essential for blood testing)
Henry et al. (1998) conducted the first study to determine if silicon microneedles could
be used to increase transdermal drug delivery. The penetration of microneedles through
the upper layer of skin (stratum corneum) created direct pathways for molecules that
would not normally be able to diffuse through skin barrier due to size or water solubility.
In addition, Kaushik et al. (2001) tested the pain level associating with the insertion of
silicon microneedle arrays into human skin in vivo. The study showed that the
Chetan N. Chauhan 14 SSPC, Mehsana
Microneedles in Drug Delivery system 2010-11
microneedles caused an insignificant amount of pain compared to conventional
hypodermic needle insertion, and no subjects reported any adverse reactions.
4.1.1.3 Metal Microneedles
Metal is considered a better alternative material for microneedles since it has good
mechanical strength, is relatively inexpensive and can be fabricated with ease. Solid,
stainless steel microneedles can be made by a laser-cutting technique. The resulting
needle structures are bent out of the sheet, and electropolished. The needles can be in
either single microneedles or multi-needle array form. Martanto et al (2004) used
stainless steel solid microneedles to deliver insulin to diabetic hairless rats in vivo. Needle
arrays were inserted into the rat skin using a high-velocity injector. A solution of insulin
was placed on top of the microneedle arrays and left in place for 4 h. Over this time
period, blood glucose level steadily decreased by as much as 80% compared to the
control subject.18, 36
4.1.1.4 Polymer microneedles
Polymers have also been used to form arrays of microneedles. In comparison to silicon
counterparts, polymer microneedles offer the mechanical advantage of improved
resistance to shear induced breakage. Unfortunately, this comes at the cost of reduced
sharpness at the tip of the microneedle due to low modulus and yield strength of the
polymers. Chemically, biodegradable polymers allow additional functionality of the
microneedles themselves. Rather than simply piercing the skin to create pathways for
therapeutic molecules, the microneedles themselves become drug depots implanted in the
skin.2, 34
4.1.2 Hollow Microneedles
Skin permeability can be dramatically increased by the holes created from solid
microneedles insertions. However, it is still necessary to have more controlled and
reproducible transport pathways to delivery drugs into the tissue. The fabrication of
hollow microneedles that allow transport through the hollow shaft of the needle was
based on this need. The inclusion of a hollow lumen in a microneedle structure expands
its capabilities dramatically and can offer the following advantages:
The ability to deliver larger molecules and particles;
Chetan N. Chauhan 15 SSPC, Mehsana
Microneedles in Drug Delivery system 2010-11
Deliver material in a convective transport fashion (for example, pressure-driven
flow) instead of passive diffusion;
Minimize the cross-contamination of the deliverables and its surrounding.
A variety of hollow microneedles has been fabricated and has demonstrated success in
transdermal drug delivery. As expected these benefits come at the cost of increased
complexity.
Figure 4: Hollow Microneedles
4.1.2.1 Silicon hollow microneedles
The most logical technique for the inclusion of a lumen in the silicon spikes presented is
the addition of an etching step to form a fluidic channel using standard photolithography
and isotropic-anisotropic etching combination. The fabrication steps include coating
silicon dioxide on a silicon wafer, patterning the backside of the wafer and etching
through the wafer stopping on the upper oxide layer to define the needle lumen. Silicon
nitride was then deposited, and a larger circular mask was patterned on the front side and
underetched to create the tapering effect of the microneedle. After both silicon dioxide
and silicon nitride layers were removed, symmetrical and asymmetrical needle structures
can be achieved by adjusting the relative position of the isotropic and anisotropic etching
axis. The hollow silicon structures have been created in three-dimensional arrays out of
the substrate plane. 10, 18
Chetan N. Chauhan 16 SSPC, Mehsana
Microneedles in Drug Delivery system 2010-11
4.1.2.2 Metal hollow microneedles
Hollow metal microneedles can be creating using laser micromachining (Davis 2003).
Microneedles with straight walls (i.e. that is not tapered) are fabricated using molds with
cylindrical holes created either by reactive ion etching (RIE) through silicon wafers or
lithographically defining holes in SU-8 photoresist polymer. A thin coating of metal was
then electrodeposited onto the molds to produce the desired microneedles. Tapered
hollow needle was fabricated either by obtaining a mold from a silicon master or laser
drilling tapered holes into polymer sheets, followed by electrodeposition of a thin metal
coating onto the mold. 18, 21
4.1.2.3 Glass hollow microneedles
Hollow, glass microneedles can be quickly produced with different geometric parameters
for small-laboratory use. These needles are physically capable of insertion into the tissue
without breaking, having a larger drug loading dose and permitting visualization of the
deliverables. Thin glass capillaries were placed within a micropipette puller, and could
have either a blunt or a beveled tip, which allowed ease of needle insertion into the tissue.
Coupling with an insertion apparatus, the insertion depth of the needle into the tissue can
be controlled precisely. 40, 44
McAllister et al. (2003) used single glass microneedles inserted into the skin of diabetic
hairless rats in vivo to deliver insulin during a 30-min infusion period. The needles had a
tip radius of 60 μm and were inserted into the tissue of a depth of 500-800 μm. The
results indicated an up to 70% drop in blood glucose level over a 5-h period after the
insulin was administered. Using single, beveled-tip microneedles, Martanto et al. (2006)
examined the effect of different experimental parameters on microinfusion through
hollow glass microneedles into human skin in vitro. The study reported that partial
retraction of the needle within the tissue increased delivery flow rate 10-fold compared to
that without retraction. Infusion rates could also be increased at a greater insertion depth,
a larger infusion pressure, a beveled-tip instead of a blunt tip and the addition of
hyaluronidase enzyme. 21
Chetan N. Chauhan 17 SSPC, Mehsana
Microneedles in Drug Delivery system 2010-11
4.1.3 Other types of microneedles
Besides solid and hollow microneedles, various other types of microneedles were
fabricated using different materials such as biodegradable polymers, polysilicon and
sugar with additional functionalities. Because of their biocompatible nature with the
tissue, biodegradable polymer microneedles were developed. These needles were
fabricated by initially making master structures using lithography-based methods,
creating inverse structures from the master molds, and finally producing replicate
microneedles by melting biodegradable polymer formulations (i.e. poly-lactic acid, PLA,
or poly-lactic-co-glycolic acid, PLGA) into the molds. The resulting microneedles can be
loaded with molecules, drugs, DNA or proteins. Unlike solid and hollow microneedles,
polymer microneedles themselves serve as the drug implants after insertion into the
tissue. 30, 37
Microneedles made out of maltose mixed with ascorbate were developed for transdermal
delivery of drugs. The lengths of these needles were ranging from 150 μm to 2 mm. A
clinical experiment was performed to test the biosafety and basic tolerance of these
microneedles. The tests showed the sugar-based microneedles spontaneously dissolved
and released ascorbate into epidermis and dermis of human skin. No dermatological
problems were reported. Aside from being a drug delivery tool, microneedles can also be
used as a biosensor. One major reason for loss of biosensor activity is through the settling
of large molecular weight compounds onto the sensor and affecting senor signal stability.
A microdialysis microneedle is fabricated that is capable of excluding large MW
compounds 19
4.2 Delivery Strategies
A number of delivery strategies have been employed to use the microneedles for
transdermal drug delivery. These include:
4.2.1 Poke and patch approach
This method uses microneedles to make holes and to apply a transdermal patch to the
skin surface.5 Transport can occur via diffusion or possibly iontophoresis if an electric
field is applied.
Chetan N. Chauhan 18 SSPC, Mehsana
Microneedles in Drug Delivery system 2010-11
Insulin delivery using poke and patch approach:
Insulin was delivered to diabetic hairless rat’s in-vivo. Microneedle arrays were inserted
into the skin using a high velocity injector and shown by embed fully within the skin. A
solution of insulin was placed on the top of the microneedle array and left in place for 4
hours. Over this time period blood glucose levels steadily decreased by as much as 80%.
Insulin placed on the skin surface without microneedles did not have any significant
effects. 5, 20
4.2.2 Coat and poke
Another approach is coat and poke where the needles are first coated with the drug and
then inserted into the skin. There is no drug reservoir on the skin surface; the entire drug
to be delivered is on the needle itself.
A variation on this method is the dip and scrape where microneedles are first dipped into
the drug solution and then scrapped across the skin surface to leave behind the drug
within micro abrasions created by microneedles.5
Protein vaccine delivery using coat and poke method
Examination of microneedles to deliver ovalbumin as model protein was done using coat
and poke method. Antigen release from the needle surface was found to occur quickly
where upto 20mg could be released in five sec. 20
4.2.3 Biodegradable microneedles
It involves injecting the drug through the needle with a hollow bore. This approach is
more reminiscent of an injection than a patch.
Chetan N. Chauhan 19 SSPC, Mehsana
Microneedles in Drug Delivery system 2010-11
5. Microfabrication
MEM is an acronym for Microelectromechanical systems. These gained popularity in the
1960’s in the microelectronics industry when sensors were integrated with the electronic
circuits. These are systems that have either mechanical or electric devices typically
containing sub millimeter feature sizes. Slowly, the field of MEMS became distinct
division from microelectronics and commercial products became available.
They are used to make pressure, temperature, chemical and vibration sensors, light
reflectors and switches as well as accelerometers for airbags, vehicle control, pacemakers
and games. The technology is also used to make inkjet print heads, microactuators for
read/write heads and all-optical switches that reflect light beams to the appropriate output
port.13, 35
5.1 General fabrication of microneedles
The various patterns used in depositing layers and doping regions on the substrate are
defined by a process called lithography. 45
Simply put, the lithography process generally consists of the following steps.
A layer of photo resist (PR) material is first spin-coated on the surface of the wafer.
The resist layer is then selectively exposed to radiation such as ultraviolet light,
electrons, or x-rays, with the exposed areas defined by the exposure tool, mask, or
computer data.
After exposure, the PR layer is subjected to development which destroys
unwanted areas of the PR layer, exposing the corresponding areas of the
underlying layer.
Depending on the resist type, the development stage may destroy either the
exposed or unexposed areas. The areas with no resist material left on top of them
are then subjected to additive or subtractive processes, allowing the selective
deposition or removal of material on the substrate.
Photo resist materials consist of three components:
A matrix material (also known as resin), which provides body for the photo resist
The inhibitor (also referred to as sensitizer), which is the photoactive ingredient
The solvent, which keeps the resist liquid until it is applied to the substrate.
Chetan N. Chauhan 20 SSPC, Mehsana
Microneedles in Drug Delivery system 2010-11
Most lithography based MEMS fabrication processes are either additive or subtractive. In
general the following processes are used in the block building processes.
Patterning and masking a region for deposition, depositing the material and removing
the mask.
Depositing a material, masking a region for removal and stripping away the material
for deposition.
On a fundamental level these processes include deposition of the materials (additive),
etching of the materials (subtractive) thus enabling the process of patterning. These are
described below:
5.1.1 Etching Processes
Definition of Etch:
A category of lithographic processes that remove material from selected areas of a die.
Examples are nitride etch and oxide etch
Figure 5: Outline of etching process
Chetan N. Chauhan 21 SSPC, Mehsana
Microneedles in Drug Delivery system 2010-11
There are two basic categories of etching processes:
Wet etching
Dry etching.
In the former, the material is dissolved when immersed in a chemical solution. In the
latter, the material is sputtered or dissolved using reactive ions or a vapor phase etchant.
Table 1: Comparison of Dry and Wet etching processes
5.1.1.1 Wet Etching
Wet Etching is an etching process that utilizes liquid chemicals or etchants to remove
materials from the wafer, usually in specific patterns defined by photoresist masks on the
wafer. Materials not covered by these masks are 'etched away' by the chemicals while
those covered by the masks are left almost intact.14,15
A simple wet etching process may just consist of dissolution of the material to be
removed in a liquid solvent, without changing the chemical nature of the dissolved
material. In general, however, a wet etching process involves one or more chemical
reactions that consume the original reactants and produce new species.
A basic wet etching process may be broken down into three basic steps:
Diffusion of the etchant to the surface for removal;
Reaction between the etchant and the material being removed;
Diffusion of the reaction byproducts from the reacted surface
Chetan N. Chauhan 22 SSPC, Mehsana
Microneedles in Drug Delivery system 2010-11
Due to the chemical nature of this etching process, a good selectivity can often be
obtained, which means that the etching rate of the target material is considerably higher
than that of the mask material if selected carefully.
Some single crystal materials, such as silicon, will have different etching rates depending
on the crystallographic orientation of the substrate. This is known as anisotropic etching
and one of the most common examples is the etching of silicon in KOH (potassium
hydroxide), where Si <111> planes etch approximately 100 times slower than other
planes (crystallographic orientations). Therefore, etching a rectangular hole in a (100)-Si
wafer will result in a pyramid shaped etch pit with 54.7° walls, instead of a hole with
curved sidewalls as it would be the case for isotropic etching, where etching progresses at
the same speed in all directions. Long and narrow holes in a mask will produce v-shaped
grooves in the silicon. The surface of these grooves can be atomically smooth if the etch
is carried out correctly, with dimensions and angles being extremely accurate.
Wet etching is generally isotropic, i.e., it proceeds in all directions at the same rate. An
etching process that is not isotropic is referred to as 'anisotropic.' An etching process
that proceeds in only one direction (e.g., vertical only) is said to be 'completely
anisotropic'.
Lateral etch ratio (RL) = Horizontal etch rate
Vertical etch rate
Isotropic Etching: RL = 1
Anisotropic Etching: 0<RL<1
Directional Etching: RL=0
Chetan N. Chauhan 23 SSPC, Mehsana
Microneedles in Drug Delivery system 2010-11
Figure 6: Illustration of Isotropic,Anisotropic and directional etching
Reduction-oxidation (redox) reactions are commonly encountered in wafer fab wet
etching processes, i.e., an oxide of the material to be etched is first formed, which is then
dissolved, leading to the formation of new oxide, which is again dissolved, and so on
until the material is consumed.
When an isotropic etchant eats away a portion of the material under the mask, the etched
film is said to have 'undercut' the mask. The amount of 'undercutting' is a measure of an
etching parameter known as the 'bias.' Bias is defined as the difference between the
lateral dimensions of the etched image and the masked image or simply it is the
difference in the lateral dimensions between the features on the mask and the actually
etched pattern. Thus, the mask used in etching must compensate for whatever bias an
etchant is known to produce, in order to create the desired feature on the wafer. Smaller
RL results in smaller bias.
Chetan N. Chauhan 24 SSPC, Mehsana
Microneedles in Drug Delivery system 2010-11
Another important consideration in any etching process is the 'selectivity' of the etchant.
An etchant not only attacks the material being removed, but the mask and the substrate
(the surface under the material being etched) as well. The 'selectivity' of an etchant
refers to its ability to remove only the material intended for etching, while leaving the
mask and substrate materials intact.
Selectivity, S, is measured as the ratio between the different etch rates of the etchant for
different materials. Thus, a good etchant needs to have a high selectivity value with
respect to both the mask (Sfm) and the substrate (Sfs), i.e., its etching rate for the film
being etched must be much higher than its etching rates for both the mask and the
substrate.
Despite the resolution limitations of wet etching, it has found widespread use because of
its following advantages:
Low cost;
High reliability;
High throughput; and
Excellent selectivity in most cases with respect to both mask and substrate materials
Automated wet etching systems add even more advantages:
Greater ease of use;
Higher reproducibility; and
Better efficiency in the use of etchants.
Of course, like any process, wet etching has its own disadvantages. These include the
following:
Limited resolution;
Higher safety risks due to the direct chemical exposure of the personnel;
High cost of etchants in some cases;
Problems related to the resist's loss of adhesion to the substrate;
Problems related to the formation of bubbles which inhibit the etching process where
they are present;
Problems related to incomplete or non-uniform etching.
Chetan N. Chauhan 25 SSPC, Mehsana
Microneedles in Drug Delivery system 2010-11
Silicon (single-crystal or poly-crystalline) may be wet-etched using a mixture of nitric
acid (HNO3) and hydrofluoric acid (HF). The nitric acid consumes the silicon surface to
form a layer of silicon dioxide, which in turn is dissolved away by the HF. The over-all
reaction is as follows:
Si + HNO3 + 6 HF H2SiF6 + HNO2 + H2 + H2O.
Silicon dioxide may, as mentioned above, be wet-etched using a variety of HF
solutions. The over-all reaction for this is:
SiO2 + 6 HF H2 + SiF6 + 2 H2O.
Water-diluted HF with some buffering agents such as ammonium fluoride (NH4F) is a
commonly used SiO2 etchant formulation
Wet etching of aluminum and aluminum alloy layers may be achieved using slightly
heated (35-45 deg C) solutions of phosphoric acid, acetic acid, nitric acid, and water.
Again, the nitric acid consumes some of the aluminum material to form an aluminum
oxide layer. This oxide layer is then dissolved by the phosphoric acid and water, as more
Al2O3 is formed simultaneously to keep the cycle going.
5.1.1.2 Dry Etching
Dry Etching is an etching process that does not utilize any liquid chemicals or etchants
to remove materials from the wafer, generating only volatile by products in the process.
Dry etching may be accomplished by any of the following:
Through chemical reactions that consume the material, using chemically reactive
gases or plasma (plasma etching)23
Physical removal of the material, usually by momentum transfer (physical sputtering
and ion beam milling)
A combination of both physical removal and chemical reactions. (Reactive ion
etching)
Dry etching refers to the removal of material, typically a masked pattern of
semiconductor material, by exposing the material to a bombardment of ions (usually a
plasma of reactive gases such as fluorocarbons, oxygen, chlorine, boron trichloride;
sometimes with addition of nitrogen, argon, helium and other gases) that dislodge
portions of the material from the exposed surface.
The main purpose of developing dry etching is to achieve anisotropic etching.
Chetan N. Chauhan 26 SSPC, Mehsana
Microneedles in Drug Delivery system 2010-11
Figure 7: Illustration of dry etching
Plasma etching, a purely chemical dry etching technique, basically consists of the
following steps:
Generation of reactive species in a plasma;
Diffusion of these species to the surface of the material being etched;
Adsorption of these species on the surface;
Occurrence of chemical reactions between the species and the material being etched,
forming volatile byproducts;
Desorption of the byproducts from the surface; and
Diffusion of the desorbed byproducts into the bulk of the gas.
The reactive species used in dry chemical etching must be selected so that the following
criteria are met:
High selectivity against etching the mask material over the layer being etched;
High selectivity against etching the material under the layer being etched;
Chetan N. Chauhan 27 SSPC, Mehsana
Microneedles in Drug Delivery system 2010-11
High etch rate for the material being removed;
Excellent etching uniformity.
They should also allow a safe, clean, and automation-ready etching process.
Unfortunately, most etching techniques that employ purely chemical means to remove
the material (whether through wet or dry etching) do not exhibit high anisotropy. This is
because chemical reactions can and do occur in all directions. Thus, chemical reactions
can attack in the horizontal direction and consume a portion of the material covered by
the mask, a phenomenon known as 'undercutting.'
If maximum anisotropy is of utmost concern, then dry etching techniques that employ
physical removal of material must be considered. One such technique is physical
sputtering, which involves purely physical removal of material by bombarding it with
highly energetic but chemically inert species or ions. These energetic ions collide with
atoms of the material as they hit the material's surface, dislodging these atoms in the
process.
Targeting the layer to be etched with incident ions that are perpendicular to its surface
will ensure that only the material not covered by the mask will be removed.
Unfortunately, such a purely physical process is also non-selective, i.e., it also attacks
the mask layer covering the material being etched, since the mask is also directly hit by
the bombarding species. For this reason, physical sputtering has never become popular
as a dry etching technique for wafer fabrication.
A good balance between isotropy and selectivity may be achieved by employing both
physical sputtering and chemical means in the same dry etching process. Reactive ion
etching is one such process that involves both physical and chemical means to remove
material.18, 19
Reactive ion etching (RIE)
Reactive ion etching (RIE), is sometimes referred to as reactive sputter etching (RSE),
consists of bombarding the material to be etched with highly energetic chemically
reactive ions. Such bombardment with energetic ions dislodges atoms from the material
(just like purely physical sputtering), in effect achieving material removal by sputtering.
In reactive ion etching (RIE), the substrate is placed inside a reactor in which several
gases are introduced. Plasma is struck in the gas mixture using an RF power source,
Chetan N. Chauhan 28 SSPC, Mehsana
Microneedles in Drug Delivery system 2010-11
breaking the gas molecules into ions. The ions are accelerated towards, and react at, the
surface of the material being etched, forming another gaseous material. This is known as
the chemical part of reactive ion etching. There is also a physical part which is similar in
nature to the sputtering deposition process. If the ions have high enough energy, they can
knock atoms out of the material to be etched without a chemical reaction. It is a very
complex task to develop dry etch processes that balance chemical and physical etching,
since there are many parameters to adjust. By changing the balance it is possible to
influence the anisotropy of the etching, since the chemical part is isotropic and the
physical part highly anisotropic the combination can form sidewalls that have shapes
from rounded to vertical.
RIE is a chemical-physical etching process capable of providing highly anisotropic etch
profiles with good selectivity.9–12 Anisotropy is attributed to ionic bombardment which
is basically a physical phenomenon. On the other hand, selectivity is a chemical
phenomenon that occurs on the surface to be etched due to the chemical reaction of the
active radicals and the neutral species present in the plasma thereby producing loosely
bound compound. This compound is then pumped away from the etched surface due to
physical bombardment of energetic ions present in the plasma. The degree of anisotropy
and selectivity depends on a larger number of parameters such as etch, pressure, radio
frequency (RF) power, gas flow rate and the type of reactant gas or their combinations
used. Plasma etching process was optimized for photo-resist removal using oxygen
plasma and the etching end point was determined by in-situ monitoring of the emission
spectral lines of different species present in the plasma.45
Deep reactive ion etching (DRIE)
A special subclass of RIE which continues to grow rapidly in popularity is deep RIE
(DRIE). In this process, etch depths of hundreds of micrometres can be achieved with
almost vertical sidewalls. The primary technology is based on the so-called "Bosch
process", named after the German company Robert Bosch which filed the original patent,
where two different gas compositions are alternated in the reactor. Currently there are
two variations of the DRIE. In the 1st Variation, the etch cycle is as follows: (i) SF6
isotropic etch; (ii) C4F8 passivation; (iii) SF6 anisoptropic etch for floor cleaning. In the
2nd variation, steps (i) and (iii) are combined.
Chetan N. Chauhan 29 SSPC, Mehsana
Microneedles in Drug Delivery system 2010-11
Both variations operate similarly. The C4F8 creates a polymer on the surface of the
substrate, and the second gas composition (SF6 and O2) etches the substrate. The polymer
is immediately sputtered away by the physical part of the etching, but only on the
horizontal surfaces and not the sidewalls. Since the polymer only dissolves very slowly in
the chemical part of the etching, it builds up on the sidewalls and protects them from
etching. As a result, etching aspect ratios of 50 to 1 can be achieved. The process can
easily be used to etch completely through a silicon substrate, and etch rates are 3-4 times
higher than wet etching.
In addition to sputter-removal, the bombarding ions used in RIE were chosen so that
they will chemically react with the material being bombarded to produce highly volatile
reaction byproducts that can simply be pumped out of the system. This is the reason
why RIE is widely used in wafer fabrication - it achieves the required anisotropy (by
means of sputter-removal) and the required selectivity (through chemical reactions).
Table 1 presents some examples of the process gases usually employed in the reactive
ion etching of common wafer materials.19
Material to be
EtchedExamples of Gases Used in the RIE
PolysiliconCF4; SF6; Cl2; CCl3F; etc. (w/ or w/o
oxygen)
Al; Al doped with Si,
Cu, TiCCl4; CCl4+Cl2; BCl3; BCl3+Cl2
Tungsten Fluorinated Gases
Refractory SilicidesFluorinated plus Chlorinated Gases
(w/ or w/o oxygen)
TiN; TiC Same as Al Etch
Table 2: Examples of Gases Used in the RIE of Common Wafer Materials
Chetan N. Chauhan 30 SSPC, Mehsana
Microneedles in Drug Delivery system 2010-11
5.1.2 Deposition processes
Commonly used deposition processes are: Electrodeposition, Sputter deposition, Physical
Vapour Deposition (PVD) and Chemical Vapour Deposition (CVD). The Chemical
Vapor Deposition Process is a very intricate process which takes place in several steps.
5.1.2.1 Electrodeposition
It is the deposition of the material initiated and propogated by an electrochemical
reaction. Most commonly the term is used to identify the deposition of various metals on
to a substrate via electroplating. However in general it refers to the deposition of the
organic or inorganic substances by reactions driven externally by applying potential
(electroplating) or by in situ potential generated by chemical reactions (electrode-less or
electrode plating)
5.1.2.2 Electroplating
The general principle guiding electroplating is the reduction of a metal species onto a
desired part. The part is immersed in an electrolyte bath and an external power source
supply electrons for the reduction to occur. The anode can serve as both a electrode for
carrying the current as well as a source for replenishing the ions in the electrolyte bath.
The first practical electroplating bath was created in 1843. Metal microneedles are
formed by the deposition of nickel into molds. This includes electroplating nickel to form
microneedle itself and electroless plating of seed layer to polymer molds.
The bath is a solution of nickel sulfate, nickel chloride, and boric acid and the reaction
governing the deposition is:
Ni 2+ + 2e- Ni0
The anode is typically nickel foil which is dissolved from its ground state to replenish the
ionic species consumed in the bath. An external power supplies the electrons to reduce
the nickel species.
5.1.2.3 Elecroless plating
It occurs in a manner similar to electroplating as described above. However a chemical
reducing agent is present in the solution instead of electricity.
Chetan N. Chauhan 31 SSPC, Mehsana
Microneedles in Drug Delivery system 2010-11
Electroless plating of nickel used sodium hypophosphate as the reducing agent. Another
area of interest with regard to electroless plating is the ability to plate onto insulating
surfaces since the necessicity of the substrate serving as an electrode is obviated.
5.2 Specific Processes used in the Fabrication of Microneedles.
5.2.1 LIGA
LIGA is a german acronym that stands for Lithographic, Galvanoforming and
Abforming. This translates into lithography, electroplating and molding.
In general, the process includes the following procedure:
To form a mould using lithography
Electroplate into this mould to form a metallic structure
To remove the mould and reveal a completed structure.
If the desired parts are polymeric, the metal structures serve as the mould for the
polymeric parts.
In the past this was accomplished using polymethyl methacrylate and X-ray lithography
but later this technique was later broadened to include many other types of lithography
and mould materials. While standard lithography offers patterning in the lateral
dimension, the LIGA process offers projection in the vertical direction. 19
5.2.2 Laser Micro Machining
Three-dimensional arrays of hollow and solid microneedles have been fabricated using
laser micromachining techniques. Ultraviolet (UV) and infrared (IR) laser machining was
used to create molds for electrodeposition of metals. Mold materials included polyimide,
polyethylene terephthalate, and titanium. IR laser machining was also used to cut solid
needle designs directly from stainless steel. The mechanical stability and insertion
characteristics of hollow microneedles were tested. The force necessary for insertion was
found to vary linearly with the interfacial area of the microneedle.
The ability to crete three dimensional structures of similar quality in a single , dry step is
often reason enough to adopt laser fabrication technique. The primary disadvantage of
laser patterning is the serial nature of the process. Where lithography offers batch
fabrication, laser ablation requires each feature to be patterned individually.18,19
Chetan N. Chauhan 32 SSPC, Mehsana
Microneedles in Drug Delivery system 2010-11
5.3 Packaging of Microneedle-Based Drug Delivery Systems
Handling by patients or healthcare workers in the macroscopic world is an inherent
challenge confronting microdevices that perform biomechanical functions directly on
tissue. The current state of microfabrication technology allows the construction of precise
architectures with the limitation of physical fragility. This is especially true of hollow
high-aspect-ratio parts like microneedles. Although advances in surface-smoothing and
coatings technologies are likely to improve device robustness, it is likely that the
packaging of the microdevice will play a most important role in the development of
procedures for their use. Integration of the microdevice in a larger system that will be
handled by the practitioner and connection to a fluidic system and reservoir for solution
or dry-powder-based formulations is not a trivial undertaking. It is not unreasonable to
assume that device package as a whole “enables” the use of the microdevice, and that the
entire drug delivery package will need to be developed for testing well in advance of
clinical trials. However, the current state of development is largely focused on developing
scaleable microfabrication processes and efficacious architectures for the microdevice.1,2
Chetan N. Chauhan 33 SSPC, Mehsana
Microneedles in Drug Delivery system 2010-11
6. Commercial Microneedle Technology
A decade after the first microneedles were reported, many commercial technologies have
come into the market including the Macroflux technology, h-patch, Micro-Trans and
many more (as shown in the table)
Table 3: Commercial Microneedle technologies
6.1 Macroflux technology
Macroflux transdermal patch technology has been developed to deliver
biopharmaceutical drugs in a controlled, reproducible manner that optimizes
bioavailability and efficacy without significant discomfort for the patient. Macroflux
technology incorporates a titanium micro projection array affixed to a polymeric adhesive
back. The array has an area of up to 8 cm2 and contains as many as 300 micro projections
per cm2 with individual micro projection lengths of <200 m. The maximal adhesive
patch size is 10 cm2. A coating process is used to apply drug to the tip of each micro
projection in the array. When the patch is applied to the skin, the drug-coated micro
projections penetrate through the skin's barrier layer into the epidermis. Drug is absorbed
by the micro capillaries for systemic distribution. The rate of absorption is promoted by
the high local drug concentration around the micro projections and the large surface area
provided by the patch array.
Chetan N. Chauhan 34 SSPC, Mehsana
Microneedles in Drug Delivery system 2010-11
Following are the salient features of Macroflux:
Systemic Approach
The Macroflux patch and application system are shown in Figure below. When the
applicator is pressed onto the skin, it self-actuates to release the patch with the correct
force and timing (in milliseconds). This reusable, spring-loaded applicator ensures
reproducible patch application and uniform penetration of Macroflux microprojections
through the stratum corneum layer. The patch-application system is easy to use, requiring
no special training.
Figure 8: Figure illustrating ease of application of Macroflux
Efficient Tip Coating Process
With many traditional patch technologies, only a small percentage of drug is actually
delivered from the patch reservoir into the skin. In the current environment of cost
containment and disposal risks, this is undesirable, particularly for the more expensive,
potent biopharmaceuticals. In order to maximize the efficiency of drug incorporation into
the patch and to ensure the precision of drug transport to the skin, a coating process has
been developed that applies the drug formulation just on the tips of the Macroflux
microprojections.
Chetan N. Chauhan 35 SSPC, Mehsana
Microneedles in Drug Delivery system 2010-11
Rapid Delivery & High Bioavailability
Macroflux patches can provide rapid and efficient delivery of therapeutic agents. In the
HGP model, time to maximum plasma drug concentration (Tmax) of hGH occurred
sooner with hGH coated on Macroflux patches than with subcutaneous injection, and
bioavailability was similar
Scientists at ALZA have also demonstrated that intracutaneous Macroflux delivery of a
45-kDa protein antigen provided a better vaccine response than an equivalent dose
delivered by intramuscular or subcutaneous injection in preclinical studies.4 In addition,
Macroflux transdermal technology provided system-controlled and sustained delivery of
an antisense oligodeoxy- nucleotide, 7 kDa, achieving delivery of 15 mg over a 24-hour
period from a 2cm2 patch.
Figure 9: Component of Macroflux
ALZA has entered into partnerships to explore development of products utilizing
Macroflux transdermal technology. Preclinical work is ongoing to explore the feasibility
of using the Macroflux patch technology to deliver this peptide. Additional partnering
programs are in place including a second collaboration with Theratechnologies for an
undisclosed endocrinology product.
In summary, the Macroflux patch incorporates a drug-coated titanium micro-projection
array that offers marked advantages over other transdermal delivery systems for efficient
delivery of peptides, proteins, and other therapeutic macromolecules. Dose delivery is
Chetan N. Chauhan 36 SSPC, Mehsana
Microneedles in Drug Delivery system 2010-11
controlled by the patch size and drug loading on the microprojections. The system is
minimally invasive and well tolerated. It is convenient for users and provides controlled,
consistent dosing. Drug-coated Macroflux microprojections penetrate the skin and deliver
drug into the epidermal layer for rapid dissolution and absorption that yields high drug
utilization and bioavailability. In preclinical studies, approximately 85% of drug present
on the Macroflux array patch was delivered in less than 5 minutes patch-wearing time.
For biopharmaceuticals, the Macroflux pharmacokinetic delivery profile and
bioavailability may be equivalent to subcutaneous injection. The Macroflux patch is a
developing technology that may provide expanded drug delivery opportunities for
therapeutic peptides, proteins, and vaccines.25
6.2 h- Patch
With clearance from the US Food and Drug Administration (FDA), Valeritas' h-Patch
basal bolus insulin delivery system is poised to help Type 2 diabetes patients improve
their compliance and glycemic control with their prescribed therapy regimen.
This disposable, waterproof device is as small as a ChapStick tube and as easy to apply
as a Band-Aid bandage, making it an attractive alternative to other insulin delivery
methods such as catheter-based electronic pump systems or injections. Morever, the h-
Patch is easy, safe and convenient.
Patients simply peel the protective liner from the adhesive backing, apply the device to a
part of the body where it can be easily reached (such as the abdomen, arm or thigh), and
push the start button, which painlessly inserts the micro-needle and begins the basal flow
of insulin. When a meal-time bolus is needed, the wearer simply presses the bolus button
on the h-Patch system, which can easily be done through his or her clothing. No need to
access the device directly. The user will hear a click to indicate that the bolus has been
delivered.
When the h-Patch system is removed, the micro-needle retracts, locks in place, and
cannot be redeployed, making device disposal as easy as removing and discarding a
bandage as well as eliminating the need for sharps disposal. The h-Patch system is
designed to easily be replaced every 24 hours, allowing patients to rotate site placement
and minimize the risk for local infection.48
Chetan N. Chauhan 37 SSPC, Mehsana
Microneedles in Drug Delivery system 2010-11
Figure 10: Application of h-Patch
6.3 Micro Trans
Valeritas microneedle array patch (Micro trans) technology enables drug delivery or
interstitial fluid sensing at the epidermis or dermis, without limitations of drug size,
structure, charge, or the patient's skin characteristics. Arrays penetrate only the shallow
layers of the skin, avoiding close proximity to pain receptors, making the system
extremely comfortable for the patient to wear.
Valeritas' Microneedle Array technology consists of multiple small, hollow or solid
needles fabricated on a single surface. Microneedles can be constructed of metal or
biodegradable polymers. The length, diameter, wall thickness, and shapes can be
manufactured to a variety of specifications. Valeritas' proprietary manufacturing
processes ensure that these arrays can be fabricated at very low cost. 47
Applications Include:
Delivery of large proteins, fragile antibodies, and hormones.
Delivery of small molecules, particularly those with difficulty diffusing through skin
layers.
Delivery of vaccines, both conventional and DNA-based.
Fluid sensing of glucose, hormones, blood gases, and therapeutic drug levels.
Chetan N. Chauhan 38 SSPC, Mehsana
Microneedles in Drug Delivery system 2010-11
Key Features:
Simple for patient to use, and fully disposable.
Unique manufacturing techniques result in very low cost.
Accurate, reliable delivery of drug to epidermis or dermis, circumventing the stratum
corneum.
Passive or active drug delivery profiles.
Can be used with Valeritas' e-Patch device to deliver a wide range of drug volumes
under various extended or time-release profiles
Figure 11: Micro-Trans
Chetan N. Chauhan 39 SSPC, Mehsana
Microneedles in Drug Delivery system 2010-11
7. Future Trends
Integration of solid microneedles with transdermal patch provides a minimal invasive
method to increase the skin permeability of drugs, including the macromolecules such as
proteins. Till date, microneedles made up of silicon, metal, glass and plastics have been
utilized for transdermal delivery.
However, with rapid advancement in technology, microneedles composed of
biodegradable and biocompatible materials have been explored. For instance, fabrication
of dissolving microneedles using polysaccharide biomaterials have been utilized for
controlled drug delivery.2 Microneedle approach of drug delivery is currently being
evaluated for a number of drugs, but extensive studies would be required to foster the
application of these delivery modes in the clinical set up. However, some of the future
directions are discussed below:
7.1 Improved Microneedle Research
There are many aspects of the microneedle field which require future research. The most
important is to balance microneedle robustness with needle deformation in response to
imposed stresses. Needles must be able to tolerate forces associated with insertion, intact
removal and normal human movements if they are to be integrated into portable
biomedical devices. Materials such as silicon can easily pierce the skin but they are also
brittle materials which fracture easily. Metal and polymer needles are not stiff so they can
absorb larger stresses by deforming. However, this ability also makes piercing the skin
more difficult.
More research is needed to develop needles which balance the stiffness required for
insertion with the ability to deform to absorb stress associated with movement. Research
should include hybrid needle designs which incorporate silicon tips with polymer lumens,
or “knuckled” silicon designs with polymer coatings. Thus, the silicon could be used as a
stiff material for piercing the skin and the polymer coating would hold the needle
together and absorb stress.18
7.2 Improved Microdialysis Microneedles
Future work should focus on determining how larger biological molecules such as serum
proteins permeate a microdialysis membrane to allow optimization of the design. This
Chetan N. Chauhan 40 SSPC, Mehsana
Microneedles in Drug Delivery system 2010-11
will allow a balance between mass transfer rates and filtering effectiveness of a
membrane.18, 20
Chetan N. Chauhan 41 SSPC, Mehsana
Microneedles in Drug Delivery system 2010-11
8. Conclusion
Microneedles are needle-like structures which are fabricated on substrates like silicon.
Other materials include: metals, silicon dioxide, polymers, and glass. With the use of
photolithography and various etching methods, it will give the profile of these needles.
Various shapes can also be fabricated to have structures that are straight, bent, filtered
and hollow. Microneedles are applied in the medical field for such applications as: a
blood glucose measurement device, transdermal delivery device, and skin therapy.
Although microneedles will not fully replace the traditional needles, they do, however
posses certain capabilities that traditional needles do not.
Chetan N. Chauhan 42 SSPC, Mehsana
Microneedles in Drug Delivery system 2010-11
9. References
1. James A Down, Noel G Harvey; Transdermal Drug Delivery; Marcel Dekker Inc.
2. Mark R Praunitz ; Microfabricated Microneedles and Transdermal drug Delivery
Technology; Modified Release Drug Delivery Technology; Marcel Dekker Inc.;513-
522
3. Kenneth A Walters; Drug Delivery:Topical and Transdermal Routes;Encyclopedia of
Pharmaceutical Technology- Third Edition;1319
4. Jing Ji, Francis E.H Tay et al; Microfabricated Silicon Microneedle array for
Transdermal Drug Delivery ; Journal of Physics: Conference series34(2000)1127-
1131
5. Pushpat Bora,Lokesh Kumar, Arvind Bansal;Microneedle Technology for Advanced
drug Delivery-Evolving Vistas;Department of Pharmaceutical Technology;NIPER
6. E.R Parker,M.P Rao, K.L Turner; Mechanical & Environmental
Engineering;University of California;USA
7. Jeffery David Zahu; Microfabricated Microneedles & minimally invasive drug
delivery sampling & Analysis;University of California
8. Microneedles: A new Alternative to Hypodermic syringes; MNT
network(www.mntnetwork.com)
9. Nicolle Wilke;Micromachined Silicon and Polymer MicroneedleArrays for cancer
therapy & drug delivery
10. Phil Green, Franklin lakes;Delivery of Macromolecules using Microneedles;BD-
NJ,USA
11. Hurat Karabiyukoglu;New Frontiers in Transdermal Drug Delivery System;Drug
Delivery Report Spring Summer;2007
12. Ritesh Kumar, Anil Philip;Modified Transdermal Technology:Breaking the barriers
of Drug Permeation via Skin; March 2007;6(1);633-644
13. Firas Sammoura , Jeo Jon Kong et al ; Polymeric microneedle for using
microinjection using Microinjection mould Technology ; Microsyst Technology
(2007)13;517,522
14. Microneedle Therapy System ; Prof. Kim Beom Jaon
Chetan N. Chauhan 43 SSPC, Mehsana
Microneedles in Drug Delivery system 2010-11
15. Fabrication of Silicon micronedles for Biomedical Applications ; Summary of work
done for BOC Bursary; Application 2006
16. Medical Diagnoistics Technologies based on Bio MEMS; Jianwei Mo; Director of
Electronic research; Kumetrix Inc.
17. Boris Stuber; Microneedles for Drug delivery and Biosensing ; Department of
Mechanical Engineering; University of British Columbia ; Canada
18. Shaun Paul Davis ; Hollow Microneedles &Molecule transport across the skin ;
Georgia institute of Technology 2003
19. Ninghao Jiang ; Ocular Drug Delivery using Micronedles; Georgia institute of
Technology 2003
20. Pharma Bioworld; July 2008;6(12)
21. Oddvar Sorasen;Microsystems in Biomedical Engineering; Department of
Informatics; 2004
22. Bangtao Chen, Jiashen Wei, Francis E.H. Tay, Yee Ting Wong , Ciprian Iliescu;
Silicon microneedles array with biodegradable tips for Transdermal drug delivery;
DTIP ; April 2007
23. A. K. Paul, A. K. Dimri and R. P. Bajpai; Plasma etching processes for the realization
of micromechanical structures for MEMS ; J. Indian Inst. Sci., Nov.-Dec. 2001, 81
669-674.
24. Royal pharmaceutical Society of Great Britan; News Release; Microscopic Needles
could Revolutionise eye Treatment
25 James A. Matriano, Michel Cormier, Juanita Johnson, Wendy A. Young, Margaret
Buttery, Kofi Nyam, Peter E. Daddona ; Macroflux_ Microprojection Array Patch
Technology: A New and Efficient Approach for Intracutaneous Immunization;
Pharmaceutical Research, Vol. 19, No. 1, January 2002
26. Timothy Olsen, Drug Delivery to the Suprachoroidal Space Shows Promise; Retina
Today ; April 2007
27. www.ivos.org
28. www.cmoset.com
29. www.etd.gatech.edu
30. www.tyndall.ie
Chetan N. Chauhan 44 SSPC, Mehsana
Microneedles in Drug Delivery system 2010-11
31. www.me.berkeley.edu
32. www.engr.ucsb.edu
33. www.anesthesia-analgesia.org
34. www.nicolle-wilke.de
35. www.nanocentral.eu
36. www.aapspharmaceutica.com
37. www.imre.a-star.edu.sg
38. www.clinicalresolution.com
39. www.retinatoday.com
40. www.ibn.a-star.edu
41. www.nicolle-wilke.de
42. www.iop.org
43. www.wipo.int
44. www.cacshq.org
45. www.wikipedia.com
46. www.siliconvalley.com
47. www.drugdeliverytech.com
48. www.valeritas.com
Chetan N. Chauhan 45 SSPC, Mehsana